SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
1-Year Est. Return 40.04%
This Quarter Est. Return
1 Year Est. Return
+40.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$103M
AUM Growth
-$21.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1 +$7.85M
2 +$1.83M
3 +$1.73M
4
EDSA icon
Edesa Biotech
EDSA
+$1.68M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$1.43M

Top Sells

1 +$2.87M
2 +$2.66M
3 +$1.56M
4
VSTM icon
Verastem
VSTM
+$1.55M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.23M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
51
Acadia Pharmaceuticals
ACAD
$3.81B
$186K 0.18%
93,393
-126,607
CRBP icon
52
Corbus Pharmaceuticals
CRBP
$179M
$186K 0.18%
+35,000
VNDA icon
53
Vanda Pharmaceuticals
VNDA
$260M
$161K 0.16%
35,148
+10,148
PYPD icon
54
PolyPid
PYPD
$58M
$149K 0.15%
54,975
-48,693
AMRN
55
Amarin Corp
AMRN
$327M
$105K 0.1%
32,581
+26,868
ELAN icon
56
Elanco Animal Health
ELAN
$10.7B
$105K 0.1%
+10,000
ZNTL icon
57
Zentalis Pharmaceuticals
ZNTL
$92.3M
$95.4K 0.09%
+60,000
WHWK
58
Whitehawk Therapeutics
WHWK
$97.6M
$83.1K 0.08%
+46,698
SVRA icon
59
Savara
SVRA
$795M
$80.5K 0.08%
+29,079
IOVA icon
60
Iovance Biotherapeutics
IOVA
$832M
$66.6K 0.06%
+20,000
THTX
61
DELISTED
Theratechnologies
THTX
$36.2K 0.04%
+25,825
ADMA icon
62
ADMA Biologics
ADMA
$3.46B
$24.3K 0.02%
810,000
-431,032
EBS icon
63
Emergent Biosolutions
EBS
$534M
$24.3K 0.02%
+5,000
NKTX icon
64
Nkarta
NKTX
$139M
$18.4K 0.02%
+10,000
APRE icon
65
Aprea Therapeutics
APRE
$7.17M
$14.4K 0.01%
102,242
-46,979
ESPR icon
66
Esperion Therapeutics
ESPR
$616M
$14.4K 0.01%
+10,000
ABVX
67
Abivax
ABVX
$8.19B
-15,000
ALLR
68
Allarity Therapeutics
ALLR
$16.7M
-67,289
ANTX icon
69
AN2 Therapeutics
ANTX
$31.2M
-196,732
ELEV
70
DELISTED
Elevation Oncology
ELEV
-200,000
IRWD icon
71
Ironwood Pharmaceuticals
IRWD
$312M
-648,785
JAZZ icon
72
Jazz Pharmaceuticals
JAZZ
$7.97B
-10,000
TSVT
73
DELISTED
2seventy bio
TSVT
-300,000
RVNC
74
DELISTED
Revance Therapeutics, Inc.
RVNC
-23,264